The loss of phosphorylation abrogates the ability of p48 to accelerate tumor cell growth both in vitro and in vivo, suggesting that CDK2-mediated phosphorylation of serine 34 of p48 is critical for the tumorigenic activity of p48 in human cancer cells26. This evidence concerns the gene CRLF3 and cancer.